Abstract:BACKGROUND: Esophageal squamous cell carcinoma (ESCC), the predominant type of esophageal cancer, has a 5-year survival rate less than 20%. Although the cause of poor prognosis is the high incidence and mortality of ESCC, the high rate of metastasis after esophageal cancer surgery is the main cause of death after the surgery. Bromodomain-containing protein 4 (BRD4), an epigenetic reader of chromatin-acetylated histones in tumorigenesis and development, plays an essential role in regulating oncogene expression. BRD4 inhibition and BRD4 inhibition-based treatment can potentially suppress ESCC growth. However, the effects and mechanisms of action of BRD4 on ESCC cell migration remain unclear.AIM: To explore the effect of BRD4 on cell migration of ESCC <i>in vitro</i> and its possible molecular mechanism.METHODS: Human ESCC cell lines KYSE-450 and KYSE-150 were used. The 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide assay was performed to examine cell proliferation, and the transwell migration assay was conducted to test ESCC cell migration. JQ1, a BRD4 inhibitor, was applied to cells, and BRD4 siRNA was transfected into ESCC cells to knockdown endogenous BRD4. GFP-RFP-LC3 adenovirus was infected into ESCC cells to evaluate the effect of JQ1 on autophagy. Western blotting was performed to determine the protein levels of BRD4, E-cadherin, vimentin, AMP-activated protein kinase (AMPK), and p-AMPK.RESULTS: BRD4 was either downregulated by small interfering RNA or pretreated with JQ1 in ESCC cells, leading to increased tumor migration in ESCC cells in a dose- and time-dependent manner. Inhibition of BRD4 not only significantly suppressed cell proliferation but also strongly increased cell migration by inducing epithelial-mesenchymal transition (EMT). The protein expression of vimentin was increased and E-cadherin decreased in a dose-dependent manner, subsequently promoting autophagy in KYSE-450 and KYSE-150 cells. Pretreatment with JQ1, a BRD4 inhibitor, inhibited BRD4-induced LC3-II activation and upregulated AMPK phosphorylation in a dose-dependent manner. Additionally, an increased number of autophagosomes and autolysosomes were observed in JQ1-treated ESCC cells. The autophagy inhibitor 3-methyladenine (3-MA) reversed the effects of BRD4 knockdown on ESCC cell migration and blocked JQ1-induced cell migration. 3-MA also downregulated the expression of vimentin and upregulation E-cadherin.CONCLUSION: BRD4 inhibition enhances cell migration by inducing EMT and autophagy in ESCC cells <i>via</i> the AMPK-modified pathway. Thus, the facilitating role on ESCC cell migration should be considered for BRD4 inhibitor clinical application to ESCC patients.

BRD4 drives esophageal squamous cell carcinoma growth by promoting RCC2 expression

Inhibition of bromodomain-containing protein 4 enhances the migration of esophageal squamous cell carcinoma cells by inducing cell autophagy

Therapeutic Targeting of BRD4 in Head Neck Squamous Cell Carcinoma

Ribosomal S6 protein kinase 4 promotes radioresistance in esophageal squamous cell carcinoma

ECRG4 Acts As a Tumor Suppressor Gene Frequently Hypermethylated in Human Breast Cancer.

High level of BRD4 promotes non-small cell lung cancer progression

RSK4 Promotes the Macrophage Recruitment and M2 Polarization in Esophageal Squamous Cell Carcinoma.

RBM4 dictates ESCC cell fate switch from cellular senescence to glutamine-addiction survival through inhibiting LKB1-AMPK-axis

BRD4 promotes pancreatic ductal adenocarcinoma cell proliferation and enhances gemcitabine resistance.

BRD4-binding Enhancer Promotes CRC Progression by Interacting with YY1 to Activate the Wnt Pathway Through Upregulation of TCF7L2.

Bromodomain protein BRD4 promotes cell proliferation in skin squamous cell carcinoma

TBRG4 silencing promotes progression of squamous cell carcinoma via regulation of CAV-1 expression and ROS formation

BRD4 Inhibition Sensitizes Cervical Cancer to Radiotherapy by Attenuating DNA Repair.

Circ_0050444 represses esophageal squamous cell carcinoma progression through sponging miR-486-3p to upregulate C10orf91

BRD4 Promotes the Stemness of Gastric Cancer Cells Via Attenuating Mir-216A-3p-mediated Inhibition of Wnt/β-catenin Signaling.

Bromodomain protein BRDT directs ΔNp63 function and super-enhancer activity in a subset of esophageal squamous cell carcinomas

BRD4 Promotes Tumor Growth and Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma.

BRD4 Inhibition Sensitizes Renal Cell Carcinoma Cells to the PI3K/mTOR Dual Inhibitor VS-5584.

RECQL4 Regulates DNA Damage Response and Redox Homeostasis in Esophageal Cancer

MicroRNA-4651 Targets Bromodomain-Containing Protein 4 to Inhibit Non-Small Cell Lung Cancer Cell Progression